COST OF BEST SUPPORTIVE CARE IN THE TREATMENT OF MODERATE-TO-SEVERE PSORIATIC ARTHRITIS IN THE UNITED STATES

被引：0
|
作者：
Tencer, T. [1 ]
Li, S. [2 ]
Zhang, F. [1 ]
机构：
[1] Celgene Corp, Summit, NJ USA
[2] Celgene Corp, Warren, NJ USA
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 03期
关键词：
D O I：
10.1016/j.jval.2013.03.1129
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A222 / A222
页数：1
相关论文
共 50 条
  • [1] COSTS OF BEST SUPPORTIVE CARE IN THE TREATMENT OF MODERATE-TO-SEVERE PSORIATIC ARTHRITIS IN THE UNITED STATES
    Tencer, T.
    Li, S.
    Zhang, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 687 - 687
  • [2] COSTS OF BEST SUPPORTIVE CARE IN THE TREATMENT OF MODERATE-TO-SEVERE PSORIASIS IN THE UNITED STATES
    Tencer, T.
    Li, S.
    Zhang, F.
    VALUE IN HEALTH, 2013, 16 (07) : A504 - A505
  • [3] Drug cost per responder for the treatment of moderate-to-severe psoriasis and active psoriatic arthritis
    Armstrong, April
    Merola, Joseph
    Yang, Min
    Li, Junlong
    Zhao, Jing
    Sundaram, Murali
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB105 - AB105
  • [4] Cost-effectiveness of tildrakizumab for the treatment of moderate-to-severe psoriasis in the United States
    Jia, Xiaoying
    Zhao, Yang
    Carrico, Justin
    Brodtkorb, Thor-Henrik
    Mendelsohn, Alan M.
    Lowry, Simon
    Feldman, Steve
    Wu, Jashin J.
    Armstrong, April W.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (02) : 740 - 748
  • [5] Ixekizumab for treatment of adults with moderate-to-severe plaque psoriasis and psoriatic arthritis
    Vu, Trang T.
    Gooderham, Melinda
    Papp, Kim
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2016, 9 (11) : 1423 - 1433
  • [6] The direct cost of care for psoriasis and psoriatic arthritis in the United States
    Javitz, HS
    Ward, MM
    Farber, E
    Nail, L
    Vallow, SG
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2002, 46 (06) : 850 - 860
  • [7] Cost-effectiveness of omalizumab for the treatment of moderate-to-severe uncontrolled allergic asthma in the United States
    Sullivan, Patrick W.
    Li, Qianyi
    Bilir, S. Pinar
    Dang, Joseph
    Kavati, Abhishek
    Yang, Ming
    Rajput, Yamina
    CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (01) : 23 - 32
  • [8] COST-EFFECTIVENESS ANALYSIS OF IXEKIZUMAB VERSUS SECUKINUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS AND CONCOMITANT MODERATE-TO-SEVERE PSORIASIS IN THE UNITED KINGDOM
    Storck, C. T.
    Schweikert, B.
    Akerborg, O. P.
    Kumar, G.
    Nott, D. H.
    Kiri, S.
    Sapin, C.
    Hartz, S.
    VALUE IN HEALTH, 2018, 21 : S319 - S319
  • [9] Comparison of the cost-effectiveness of biologic drugs used for moderate-to-severe psoriasis treatment in the United States
    Wu, Jashin J.
    Feldman, Steven R.
    Rastogi, Shipra
    Menges, Brandy
    Lingohr-Smith, Melissa
    Lin, Jay
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2018, 29 (08) : 769 - 774
  • [10] THE IMPORTANCE OF MANAGING ARTHRITIS IN PATIENTS WITH BOTH MODERATE-TO-SEVERE PSORIASIS AND PSORIATIC ARTHRITIS
    Kirkham, B.
    Boggs, R.
    Li, W.
    Nab, H. W.
    Tarallo, M.
    VALUE IN HEALTH, 2013, 16 (03) : A227 - A227
12345